Meredith Gregory-Ksander, PhD

The destruction of retinal ganglion cells caused by the type II transmembrane protein Fas ligand (Fasl) is a key factor in glaucoma pathogenesis. Meredith Gregory-Ksander, PhD, Assistant Professor of Ophthalmology and Assistant Scientist at Schepens Eye...

A team of researchers at Harvard Medical School (HMS) and Mass Eye and Ear have successfully restored vision in elderly mice by turning back the clock on their aged nerve cells in the retina to recapture their youthful function. The team used an adeno...

The Massachusetts Lions Eye Research Fund has awarded $700,000 in grants to support research projects led by the following faculty: Beetham Eye Institute at Joslin Diabetes Center Paolo Silva, MD, will study computational fluid dynamics modeling of the...

Jason Comander, MD, PhD, received a Foundation Fighting Blindness Enhanced Career Development Award in the amount of $510,000 over three years. Meredith Gregory-Ksander, PhD, received a grant from ONL Therapeutics in the amount of $59,739 over one year to...

Mass. Eye and Ear/Harvard Medical School glaucoma researcher awarded funding by the BrightFocus Foundation. Boston, Mass. — The BrightFocus Foundation recently honored Meredith Gregory-Ksander, PhD, of the Schepens Eye Research Institute of Massachusetts...